We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $591M
1-Year Est. Return 26.48%
This Fund
S&P 500
This Quarter Est. Return
+4.31%
1 Year Est. Return
+26.48%
3 Year Est. Return
+90.92%
5 Year Est. Return
+109.52%
10 Year Est. Return
+349.63%
AUM
$446M
AUM Growth
+$11.6M
Cap. Flow
-$4.39M
Cap. Flow %
-0.98%
Top 10 Hldgs %
21.53%
Holding
590
New
16
Increased
117
Reduced
149
Closed
25

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$1.5M
2
NKE icon
Nike
NKE
+$1.46M
3
UNH icon
UnitedHealth
UNH
+$534K
4
DOW icon
Dow Inc
DOW
+$516K
5
CVS icon
CVS Health
CVS
+$459K

Sector Composition

Rank Sector Weight
1 Healthcare 17.82%
2 Financials 12.86%
3 Technology 12.77%
4 Industrials 8.32%
5 Consumer Discretionary 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
226
DELISTED
Hanesbrands
HBI
$296K 0.07%
17,175
-2,200
-11% -$37.9K
HSY icon
227
Hershey
HSY
$36.6B
$294K 0.07%
2,192
DRE
228
DELISTED
Duke Realty Corp.
DRE
$294K 0.07%
9,309
-1,493
-14% -$46.1K
CTSH icon
229
Cognizant
CTSH
$26B
$292K 0.07%
4,602
-17,368
-79% -$1.14M
HYD icon
230
VanEck High Yield Muni ETF
HYD
$4.45B
$287K 0.06%
4,500
TRP icon
231
TC Energy
TRP
$65.9B
$285K 0.06%
5,765
CCL icon
232
Carnival Corporation Ltd
CCL
$39.7B
$284K 0.06%
6,105
-13,650
-69% -$715K
NEE icon
233
NextEra Energy
NEE
$177B
$284K 0.06%
5,548
+400
+8% +$19.7K
EXPE icon
234
Expedia Group
EXPE
$37.3B
$283K 0.06%
2,130
-1,540
-42% -$190K
GILD icon
235
Gilead Sciences
GILD
$165B
$275K 0.06%
4,068
-597
-13% -$39.3K
HYT icon
236
BlackRock Corporate High Yield Fund
HYT
$1.37B
$273K 0.06%
25,466
+390
+2% +$4.09K
VCSH icon
237
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$262K 0.06%
3,252
-1,375
-30% -$110K
PSX icon
238
Phillips 66
PSX
$81.4B
$244K 0.05%
2,613
IBB icon
239
iShares Biotechnology ETF
IBB
$9.77B
$240K 0.05%
2,203
TXN icon
240
Texas Instruments
TXN
$261B
$239K 0.05%
2,081
+251
+14% +$28.1K
ADP icon
241
Automatic Data Processing
ADP
$108B
$236K 0.05%
1,427
-250
-15% -$40.6K
LNT icon
242
Alliant Energy
LNT
$18B
$236K 0.05%
4,800
EW icon
243
Edwards Lifesciences
EW
$51.7B
$234K 0.05%
3,792
HUN icon
244
Huntsman Corp
HUN
$1.77B
$232K 0.05%
11,350
ENR icon
245
Energizer
ENR
$1.55B
$222K 0.05%
5,750
LLY icon
246
Eli Lilly
LLY
$1.06T
$220K 0.05%
1,984
-400
-17% -$47.1K
NSC icon
247
Norfolk Southern
NSC
$75.1B
$219K 0.05%
1,098
HSBC.PRA
248
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$219K 0.05%
8,349
-5
-0.1% -$130
CAH icon
249
Cardinal Health
CAH
$55.4B
$216K 0.05%
4,590
+308
+7% +$14.2K
IJK icon
250
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$215K 0.05%
3,804

Similar funds

Duncker Streett & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Duncker Streett & Co held 590 positions worth $446M, up 2.7% from $434M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Duncker Streett & Co's Q2 2019 filing shows 16 new, 117 increased, 149 reduced and 25 closed positions. Its largest new stake was Dow Inc: 9,776 shares worth $482K. The largest sale was Schwab US TIPS ETF, an estimated $1.47M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Duncker Streett & Co's largest Q2 2019 buy was Dow Inc: 9,776 shares worth $482K.
  • Duncker Streett & Co added most to Centene in Q2 2019, an estimated $1.5M increase.
  • Duncker Streett & Co's biggest Q2 2019 reduction was Schwab US TIPS ETF, cutting an estimated $1.47M.
  • Duncker Streett & Co fully exited Hess in Q2 2019, selling an estimated $202K.
  • Duncker Streett & Co's ten largest holdings make up 22% of its $446M portfolio in Q2 2019.
  • Duncker Streett & Co opened 16 new positions and closed 25 in Q2 2019.
  • Duncker Streett & Co's portfolio value rose 2.7% quarter-over-quarter to $446M.

Based on Duncker Streett & Co's 13F filing for Q2 2019, filed 24 Jul 2019.